Keyphrases
Randomized Controlled Trial
100%
Alcohol Use Disorder
67%
Type 2 Diabetic Patients
45%
Genetic Correlation
45%
Denmark
42%
Overweight or Obesity
41%
C-peptide
40%
Pre-diabetes (pre-DM)
37%
Bipolar Disorder
37%
Clozapine
37%
Olanzapine
37%
Critically Ill Patients
37%
Thromboprophylaxis
33%
Enoxaparin
32%
Excessive Drinking
29%
Glucagon-like
29%
Insulin Secretion
28%
Obesity
28%
Randomized Clinical Trial
28%
Liraglutide
26%
Glucose-tolerant
25%
Oral Glucose Tolerance Test
25%
New Drug Candidate
25%
First-degree Relatives of Type 2 Diabetics
25%
HNF1A
25%
Acute Kidney Injury
25%
Estrus Cycle
25%
Stable Cycles
25%
Incisional Infection
25%
Polymorphism
24%
Insulin Sensitivity
23%
Fasting Plasma Glucose
22%
Non-diabetic
22%
Serum Insulin
21%
Insulin Release
21%
Heritability
21%
Alcohol Consumption
21%
OGTT
20%
Germany
17%
Continued Use
17%
Alcohol Dependence
17%
Outpatient Clinic
17%
Treatment Facilities
17%
Physical Exercise
17%
C-peptide Response
17%
Placebo
16%
DSM-5
16%
Cardiorespiratory Fitness
16%
Patients with Schizophrenia
16%
Alcohol Intake
16%
Biochemistry, Genetics and Molecular Biology
Insulin Release
50%
Genetic Correlation
43%
Genetics
41%
Insulin Blood Level
40%
C-Peptide
38%
Glucose Tolerance Test
38%
Glucose Test
38%
Insulin Sensitivity
35%
Metabolomics
27%
Blood Plasma
27%
Offspring
27%
Hepatocyte Nuclear Factor 1
25%
Prevalence
25%
Candidate Gene
25%
Proband
20%
Transcriptomics
18%
Insulin Resistance
18%
Amino Acid
17%
Interleukin 6
17%
Blood Level
16%
Birth Weight
16%
Glucose Blood Level
15%
Genotyping
15%
Homeostasis
15%
RNA
15%
Tolbutamide
15%
Insulin Receptor
15%
Cohort Study
15%
Metabolite
15%
Genetic Association Study
15%
Cell Function
15%